This HTML5 document contains 184 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n16http://linked.opendata.cz/resource/sukl/roa/
n2http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127512/price-of-originator/
n10http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127512/reimbursement/
n3http://linked.opendata.cz/ontology/sukl/
n7http://linked.opendata.cz/resource/sukl/specialization-restriction/
n11http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127512/
n5http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127512/core-reimbursement/
skoshttp://www.w3.org/2004/02/skos/core#
n6http://linked.opendata.cz/resource/sukl/medicinal-product-packaging/0127512/price/
n18http://linked.opendata.cz/resource/sukl/indgroup/
n13http://linked.opendata.cz/resource/sukl/packing/
n12http://linked.opendata.cz/resource/sukl/company/
n15http://linked.opendata.cz/resource/sukl/active-ingredient/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/sukl/registration-state/
xsdhhttp://www.w3.org/2001/XMLSchema#
n9http://www.sukl.cz/modules/medication/
n20http://linked.opendata.cz/resource/atc/
n14http://linked.opendata.cz/resource/sukl/df/

Statements

Subject Item
n2:0127512
rdf:type
n3:MedicinalProductPackaging
dcterms:title
CEFTAZIDIM MYLAN 1 G
skos:notation
0127512
n3:hasATCCode
n20:J01DD02
n3:hasActiveIngredient
n15:CEFTAZIDIMUM-PENTAHYDRICUM
n3:hasDefinedDailyDose
n11:ddd
n3:hasDosageForm
n14:PLV-SOL-INJ-INF
n3:hasPackagingSize
5
n3:hasPacking
n13:VIA
n3:hasRegistrationHolder
n12:MYSF
n3:hasRegistrationState
n8:R
n3:hasRouteOfAdministration
n16:INJ-INF
n3:hasStrength
1GM/LAH
n3:hasIndicationGroup
n18:15
n3:hasSpecializationRestriction
n7:ATB
n3:containsDefinedDailyDoses
1.25
n3:hasRegistrationCode
15/ 423/08-C
n3:hasTitleSupplement
INJ+INF PLV SOL 5X1GM
n3:containsUsualTherapeuticalDailyDoses
1.25
n3:hasBreakMarketingDate
2014-12-19+01:00
n3:hasCoreReimbursementSpecification
n5:2013-01-01 n5:2013-10-01 n5:2013-11-01 n5:2013-08-03 n5:2013-09-01 n5:2014-02-01 n5:2014-03-01 n5:2013-12-01 n5:2014-01-01 n5:2013-03-01 n5:2013-04-01 n5:2013-01-05 n5:2013-02-01 n5:2013-07-01 n5:2013-08-01 n5:2013-05-01 n5:2013-06-01 n5:2014-11-01 n5:2014-11-19 n5:2014-10-01 n5:2014-10-02 n5:2015-01-13 n5:2015-02-01 n5:2014-12-01 n5:2015-01-01 n5:2014-06-01 n5:2014-06-13 n5:2014-04-01 n5:2014-05-01 n5:2014-08-01 n5:2014-09-01 n5:2014-07-01 n5:2014-07-03 n5:2015-04-02 n5:2015-05-01 n5:2015-03-01 n5:2015-04-01 n5:2015-07-02 n5:2015-06-01 n5:2015-07-01
n3:hasPriceOfOriginatorSpecification
n4:2014-12-01 n4:2015-01-01 n4:2014-11-01 n4:2014-11-19 n4:2014-10-01 n4:2014-10-02 n4:2015-07-02 n4:2015-06-01 n4:2015-07-01 n4:2015-04-02 n4:2015-05-01 n4:2015-03-01 n4:2015-04-01 n4:2014-02-01 n4:2014-03-01 n4:2013-12-01 n4:2014-01-01 n4:2013-10-01 n4:2013-11-01 n4:2013-08-03 n4:2013-09-01 n4:2014-08-01 n4:2014-09-01 n4:2014-07-01 n4:2014-07-03 n4:2014-06-01 n4:2014-06-13 n4:2014-04-01 n4:2014-05-01 n4:2013-01-01 n4:2013-07-01 n4:2013-08-01 n4:2013-05-01 n4:2013-06-01 n4:2013-03-01 n4:2013-04-01 n4:2013-01-05 n4:2013-02-01 n4:2015-01-13 n4:2015-02-01
n3:hasPriceSpecification
n6:2013-01-01 n6:2015-03-01 n6:2015-04-01 n6:2015-04-02 n6:2015-05-01 n6:2015-06-01 n6:2015-07-01 n6:2015-07-02 n6:2014-04-01 n6:2014-05-01 n6:2014-06-01 n6:2014-06-13 n6:2014-07-01 n6:2014-07-03 n6:2014-08-01 n6:2014-09-01 n6:2014-10-01 n6:2014-10-02 n6:2014-11-01 n6:2014-11-19 n6:2014-12-01 n6:2015-01-01 n6:2015-01-13 n6:2015-02-01 n6:2013-01-05 n6:2013-02-01 n6:2013-03-01 n6:2013-04-01 n6:2013-05-01 n6:2013-06-01 n6:2013-07-01 n6:2013-08-01 n6:2013-08-03 n6:2013-09-01 n6:2013-10-01 n6:2013-11-01 n6:2013-12-01 n6:2014-01-01 n6:2014-02-01 n6:2014-03-01
n3:hasReimbursementSpecification
n10:2014-11-01 n10:2014-11-19 n10:2014-10-01 n10:2014-10-02 n10:2015-01-13 n10:2015-02-01 n10:2014-12-01 n10:2015-01-01 n10:2015-04-02 n10:2015-05-01 n10:2015-03-01 n10:2015-04-01 n10:2015-07-02 n10:2015-06-01 n10:2015-07-01 n10:2013-10-01 n10:2013-11-01 n10:2013-08-03 n10:2013-09-01 n10:2014-02-01 n10:2014-03-01 n10:2013-12-01 n10:2014-01-01 n10:2014-06-01 n10:2014-06-13 n10:2014-04-01 n10:2014-05-01 n10:2014-08-01 n10:2014-09-01 n10:2014-07-01 n10:2014-07-03 n10:2013-01-01 n10:2013-03-01 n10:2013-04-01 n10:2013-01-05 n10:2013-02-01 n10:2013-07-01 n10:2013-08-01 n10:2013-05-01 n10:2013-06-01
n3:hasResumedMarketingDate
2010-06-14+02:00
n3:hasUsualTherapeuticalDailyDose
n11:utdd
n3:spcFile
http%3A%2F%2Fwww.sukl.cz%2Fmodules%2Fmedication%2Fdownload.php%3Ffile%3DSPC49170.pdf%26type%3Dspc%26as%3Dceftazidim-mylan-1-g-spc
n3:spcUri
n9:download.php?file=SPC49170.pdf&type=spc&as=ceftazidim-mylan-1-g-spc